Impact of inhibitors on treatment patterns and disease burden in Chinese patients with hemophilia: a cross-sectional study

Background Systematic investigations on the impact of inhibitors on treatment modalities and overall disease burden in Chinese hemophilia patients based on real-world data remain limited.Research design and methods We analyzed a cross-sectional survey of 543 patients diagnosed with hemophilia in China as of 31 December 2022. Treatment, bleeding, and cost items used recall periods specified in the questionnaire. Group comparisons were descriptive and exploratory.Results The mean age of participants was 26.0 ± 14.8 years, with 99.63% being male. The inhibitor-positive group had a higher proportion of severe hemophilia (93.64% vs. 76.56%, p < 0.001). 54.88% of the patients had disability certificates, and the proportion increased with age. Nearly 90% of the patients older than 30 years had different degrees of disability. The median annual bleeding rate was 20 (IQR 8–36) episodes in inhibitor-positive patients versus 12 (IQR 3–30) in inhibitor-negative patients (p = 0.008). The mean annual prophylaxis infusion frequency was 127.71 ± 54.11 infusions per year (approximately 2.5 infusions per week; median 120, IQR 96–168), with a mean factor consumption per infusion of 21.16 ± 8.28 IU/kg. The average annual per-patient cost was CNY 520,415 ± 773,627, of which the cost of factor therapy was CNY 279,402 ± 627,427.Conclusion In this selected survey sample, inhibitor-positive patients reported a higher median number of bleeding episodes and greater treatment complexity.

Authors

Institutions

Publication Details

Journal
Expert Review of Hematology
Published
2026-11-15
DOI
https://doi.org/10.1080/17474086.2026.2758943
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of inhibitors on treatment patterns and disease burden in Chinese patients with hemophilia: a cross-sectional study

Lei Gan, Jing Wu, Tao Guan, Xuefei Bai et al.
Expert Review of Hematology
Hemophilia Treatment and Research
article

Impact of inhibitors on treatment patterns and disease burden in Chinese patients with hemophilia: a cross-sectional study

Lei Gan, Jing Wu, Tao Guan, Xuefei Bai, Xiaoning He
article en

Abstract

Background Systematic investigations on the impact of inhibitors on treatment modalities and overall disease burden in Chinese hemophilia patients based on real-world data remain limited.Research design and methods We analyzed a cross-sectional survey of 543 patients diagnosed with hemophilia in China as of 31 December 2022. Treatment, bleeding, and cost items used recall periods specified in the questionnaire. Group comparisons were descriptive and exploratory.Results The mean age of participants was 26.0 ± 14.8 years, with 99.63% being male. The inhibitor-positive group had a higher proportion of severe hemophilia (93.64% vs. 76.56%, p < 0.001). 54.88% of the patients had disability certificates, and the proportion increased with age. Nearly 90% of the patients older than 30 years had different degrees of disability. The median annual bleeding rate was 20 (IQR 8–36) episodes in inhibitor-positive patients versus 12 (IQR 3–30) in inhibitor-negative patients (p = 0.008). The mean annual prophylaxis infusion frequency was 127.71 ± 54.11 infusions per year (approximately 2.5 infusions per week; median 120, IQR 96–168), with a mean factor consumption per infusion of 21.16 ± 8.28 IU/kg. The average annual per-patient cost was CNY 520,415 ± 773,627, of which the cost of factor therapy was CNY 279,402 ± 627,427.Conclusion In this selected survey sample, inhibitor-positive patients reported a higher median number of bleeding episodes and greater treatment complexity.

Expert Review of Hematology
Tianjin University (CN)
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon